The Role of the Immune System in Pathobiology and Therapy of Myocarditis: A Review

Cristina Vicenzetto,Andrea Silvio Giordani,Caterina Menghi,Anna Baritussio,Maria Grazia Peloso Cattini,Elena Pontara,Elisa Bison,Stefania Rizzo,Monica De Gaspari,Cristina Basso,Gaetano Thiene,Sabino Iliceto,Renzo Marcolongo,Alida Linda Patrizia Caforio

DOI: https://doi.org/10.3390/biomedicines12061156

IF: 4.757

2024-05-24

Biomedicines

Abstract:The role of the immune system in myocarditis onset and progression involves a range of complex cellular and molecular pathways. Both innate and adaptive immunity contribute to myocarditis pathogenesis, regardless of its infectious or non-infectious nature and across different histological and clinical subtypes. The heterogeneity of myocarditis etiologies and molecular effectors is one of the determinants of its clinical variability, manifesting as a spectrum of disease phenotype and progression. This spectrum ranges from a fulminant presentation with spontaneous recovery to a slowly progressing, refractory heart failure with ventricular dysfunction, to arrhythmic storm and sudden cardiac death. In this review, we first examine the updated definition and classification of myocarditis at clinical, biomolecular and histopathological levels. We then discuss recent insights on the role of specific immune cell populations in myocarditis pathogenesis, with particular emphasis on established or potential therapeutic applications. Besides the well-known immunosuppressive agents, whose efficacy has been already demonstrated in human clinical trials, we discuss the immunomodulatory effects of other drugs commonly used in clinical practice for myocarditis management. The immunological complexity of myocarditis, while presenting a challenge to simplistic understanding, also represents an opportunity for the development of different therapeutic approaches with promising results.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of the immune system in the pathogenesis and treatment of myocarditis. Specifically, the article aims to:

1. **Update the definition and classification of myocarditis**: Provide the latest definition and classification of myocarditis at the clinical, biomolecular, and histopathological levels to address the long - standing challenges in disease classification and diagnosis.

2. **Analyze the role of specific immune cell populations in the pathogenesis of myocarditis**: Discuss in detail the complex pathways of innate and adaptive immunity in the occurrence and development of myocarditis, and how these pathways affect myocarditis of different etiologies (infectious and non - infectious).

3. **Evaluate the therapeutic effects of immunosuppressive therapies and other drugs**: In addition to known immunosuppressants, explore the immunomodulatory effects of other commonly used drugs in the management of myocarditis, especially those that have shown efficacy in human clinical trials.

4. **Propose new treatment strategies**: Based on the complexity of the immune system, propose different treatment regimens in the hope of achieving better therapeutic effects.

Through the above research, the paper hopes to provide a more comprehensive understanding of the diagnosis and treatment of myocarditis and provide guidance for future clinical practice and research directions.